The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
Editorial Team Discusses Strategic Moves By Major Players And US Patent Listing Debate
Generics Bulletin’s editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA’s Orange Book.
